Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Vermeulen

Showing results (81-90 of 152) with videos related to

Pageof 16
Sort By:
Scientific Reports|February 23, 2012
Fusion of intestinal epithelial cells with bone marrow derived cells is dispensable for tissue homeostasisJoan H de Jong, Hans M Rodermond, Cheryl D Zimberlin, et al.
Cancer Cell International|December 9, 2020
Intestinal region-specific Wnt signalling profiles reveal interrelation between cell identity and oncogenic pathway activity in cancer developmentRonja S Adam, Sanne M van Neerven, Cayetano Pleguezuelos-Manzano, et al.
Cancer Research|January 14, 2010
The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiationKristel Kemper, Martin R Sprick, Martijn de Bree, et al.
Cell Stem Cell|March 29, 2008
Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4Matilde Todaro, Mileidys Perez Alea, Anna B Di Stefano, et al.
Frontiers in Immunology|July 24, 2024
T-cell responses in colorectal peritoneal metastases are recapitulated in a humanized immune system mouse modelJob Saris, Sanne Bootsma, Jan Verhoeff, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 7, 2020
A mouse model for peritoneal metastases of colorectal origin recapitulates patient heterogeneityVivian P Bastiaenen, Charlotte E L Klaver, Maartje C S van der Heijden, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2024
Incidence, clinical management and prognosis of patients with small intestinal adenocarcinomas from 1999 through 2019: A nationwide Dutch cohort studyTim R de Back, Jasmijn D G Linssen, Felice N van Erning, et al.
Gastroenterology|March 14, 2017
Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal TransitionEva A Ebbing, Anne Steins, Evelyn Fessler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2012
Mutations in the Ras-Raf Axis underlie the prognostic value of CD133 in colorectal cancerKristel Kemper, Miranda Versloot, Katherine Cameron, et al.
British Journal of Cancer|November 3, 2018
Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) dataAnne Trinh, Claudia Lädrach, Heather E Dawson, et al.
Pageof 16

Showing results (81-90 of 152) with videos related to

Sort By:
Pageof 16
Scientific Reports|February 23, 2012
Fusion of intestinal epithelial cells with bone marrow derived cells is dispensable for tissue homeostasisJoan H de Jong, Hans M Rodermond, Cheryl D Zimberlin, et al.
Cancer Cell International|December 9, 2020
Intestinal region-specific Wnt signalling profiles reveal interrelation between cell identity and oncogenic pathway activity in cancer developmentRonja S Adam, Sanne M van Neerven, Cayetano Pleguezuelos-Manzano, et al.
Cancer Research|January 14, 2010
The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiationKristel Kemper, Martin R Sprick, Martijn de Bree, et al.
Cell Stem Cell|March 29, 2008
Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4Matilde Todaro, Mileidys Perez Alea, Anna B Di Stefano, et al.
Frontiers in Immunology|July 24, 2024
T-cell responses in colorectal peritoneal metastases are recapitulated in a humanized immune system mouse modelJob Saris, Sanne Bootsma, Jan Verhoeff, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 7, 2020
A mouse model for peritoneal metastases of colorectal origin recapitulates patient heterogeneityVivian P Bastiaenen, Charlotte E L Klaver, Maartje C S van der Heijden, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2024
Incidence, clinical management and prognosis of patients with small intestinal adenocarcinomas from 1999 through 2019: A nationwide Dutch cohort studyTim R de Back, Jasmijn D G Linssen, Felice N van Erning, et al.
Gastroenterology|March 14, 2017
Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal TransitionEva A Ebbing, Anne Steins, Evelyn Fessler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2012
Mutations in the Ras-Raf Axis underlie the prognostic value of CD133 in colorectal cancerKristel Kemper, Miranda Versloot, Katherine Cameron, et al.
British Journal of Cancer|November 3, 2018
Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) dataAnne Trinh, Claudia Lädrach, Heather E Dawson, et al.
Pageof 16